植入前遗传学诊断技术产生的社会伦理问题及其监管对策  

Social ethical issues and countermeasures for preimplantation genetic diagnosis

作　　者：曹云霞[1] 郝燕[1] 杨芳[2] Cao Yunxia, Hao Yan, Yang Fang(Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University ; Center for Medical Humanities Research, Anhui Medical University, Hefei 230032, Chin)

机构地区：[1]安徽医科大学第一附属医院妇产科生殖医学中心,合肥230032 [2]安徽医科大学人文研究中心

出　　处：《中华生殖与避孕杂志》2018年第8期657-661,共5页Chinese Journal of Reproduction and Contraception

基　　金：国家社科基金项目(13BFX128);安徽省教育厅高校人文社会科学研究重大项目(SK2017ZD13)~~

摘　　要：体外受精(IVF)技术与分子生物学和现代遗传学相结合促成的植入前遗传学诊断(PGD)/植入前遗传学筛查(PGS)技术为有效阻断遗传病传播、从源头上实现优生开辟了广阔的前景。伴随着PGD/PGS技术的日渐成熟、安全、有效,其带来的各种伦理质疑纷至沓来。本文结合目前PGD/PGS的研究进展,阐述其应用前景及该技术带来的社会伦理问题,总结目前各国解决这些问题实施的相关举措,旨在为我国制定相关伦理指南和法律规范提供参考,推动我国相关立法进程。Preimplantation genertic diagnosis （PGD）/preimplantation genetic screening （PGS） technology, which is in vitro fertilization （IVF） technology combined with molecular biology and modem genetics, has opened up a broad prospect for effectively blocking the spread of genetic diseases and achieving eugenic. With the development of PGD/PGS, the ＂double-edged sword＂ effect of PGD/PGS has become increasingly prominent. Based on the current research progress of PGD/PGS, this paper expounds its application prospect and social ethics problems caused by the technology, and summarizes relevant measures taken by various countries to solve those problems, in order to provide references for the formulation of relevant ethics guidelines and legal norms and promote the process of relevant legislation in China.

关 键 词：植入前遗传学诊断(PGD) 设计婴儿 社会伦理 性别选择 

分 类 号：R714.8[医药卫生—妇产科学] R-052[医药卫生—临床医学]